Long Thrice Weekly Hemodialysis: The Tassin Experience

Scribner B.H. , Buri R. , Caner J.E.Z. , Hegstrom R.M. , Burnell J.M. The treatment of chronic uremia by the means of intermittent dialysis: A preliminary report. Trans ASAIO 1960; 6: 114–9.

Hegström R.M. , Murray J.S. , Pendras J.P. , Burnell J.M. , Scribner B.H. Hemodialysis in the treatment of chronic uremia. Trans ASAIO 1961; 7: 136–52.

Siddiqui J. , Kerr D.N.S. Complications of renal failure and their response to dialysis. Br Med Bull 1971; 27: 153–9.

Babb A.L. , Ahmad S. , Bergström J. , Scribner B.H. The middle molecule hypothesis in perspective. Am J Kidney Dis 1981; 1: 46.

Scribner B.H. Discussion. Trans ASAIO 1965; 11: 29–30.

Scribner B.H. , Caner J.E.Z. , Buri R. , Quinton W. The technique of continuous hemodialysis. Trans ASAIO 1960; VI: 88–103.

Scribner B.H. Dialysis therapy in the United States: a historical perspective. Home Hemodial Int 1999; 3: 9–12.

Babb A.L. , Popovich R.P. , Christopher T.G. , Scribner B.H. The genesis of the square meter-hour hypothesis. Trans ASAIO 1971; 18: 81–6.

Babb A.L. , Strand M.J. , Uvelli D.A. , Milutinovic J. , Scribner B.H. Quantitative description of dialysis treatment: a dialysis index. Kidney Int 1975; 7(suppl 2): S23–9.

Babb A.L. , Strand M.J. , Uvelli D.A. , Scribner B.H. The dialysis index: A practical guide to dialysis treatment. Dial Transplant 1977; 6: 9–12.

Cambi V. , Arisi L. , Buzio C. , Rossi E. , Savazzi G. , Migone L. Intensive utilisation of a dialysis unit. Proc EDTA 1973; 10: 342–6.

Lowrie E.G. , Laird N.M. , Parker T.F. , Sargent J.A. Effect of the hemodialysis prescription on patient morbidity. Report from the National Cooperative Study. N Engl J Med 1981; 305: 1176–81.

Gotch F.A. , Sargent J.A. A Mechanistic analysis of the National Cooperative Study (NCDS). Kidney Int 1985; 28: 526–34.

Gotch F.A. Dialysis of the future. Kidney Int 1988; 33(suppl 24): S100–4.

Keshaviah P. , Collins A. A re-appraisal of the National Cooperative study (NCDS). Kidney Int 1988; 33: 227.

Henderson L.W. Of time TAC urea and treatment schedules. Kidney Int 1988; 33(suppl 24): S105–6.

Von Albertini B. High efficiency hemodialysis: An overview. Contrib Nephrol 1988; 61: 37–45.

Collins A.J. , Keshaviah P.R. Are there limitations to shortening dialysis treatment? Trans ASAIO 1988; 34: 1–5.

Hull A.R. , Parker T.F. Proceedings from the morbidity, mortality and prescription of dialysis symposium, Dallas, Texas, September 1989: Introduction and summary. Am J Kidney Dis 1990; 15: 375–83.

Eggers P.W. Mortality rates among dialysis patients in Medicare's end-stage renal disease program. Am J Kidney Dis 1990; 25: 414–21.

Sellars L. , Robson V. , Wilkinson R. Sodium retention and hypertension with short dialysis. Br Med J 1979; 1: 520–1.

Wizemann V. , Mueller K. , Kramer W. , Schütterle G. Ten years experience with short dialysis: A decade of cardiovascular complications (Abstract). Nephrol Dial Transplant 1986; 1: 100.

Haraldson B. Higher Kt/V is needed for adequate dialysis if the treatment time is reduced. Nephrol Dial Transplant 1995; 10: 1845–51.

Scribner B.H. Blood pressure control: The neglected factor that affects survival of dialysis patients. In: Friedman E.A. , ed. Death on hemodialysis: preventable or inevitable? Kluwer Academic Publishers; 1994. pp. 195–7.

Charra B. , Calemard E. , Ruffet M. , Chazot C. , Terrat J.C. , Vanel T. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286–91.

Levin N.W. Adequacy of dialysis. Am J Kidney Dis 1994; 24: 308–16.

Ronco C. , Marcelli D. Opinions regarding outcome differences in European and US haemodialysis patients. Nephrol Dial Transplant 1999; 14: 2616–20.

Laurent G. , Calemard G. , Charra B. Long dialysis: A review of fifteen years experience in one center: 1968-1983. Proc EDTA 1983; 20: 122–9.

Twardowski Z.J. , Kubara H. Different sites versus constant sites in needle insertion into arteriovenous fistulas for treatment by repeated dialysis. Dial Transplant 1979; 8: 978–80.

Jean G. , Charra B. , Chazot C. , Vanel T. , Terrat J.C. , Hurot J.M. Long-term outcome of permanent hemodialysis catheters: A controlled study. Blood Purif 2001; 19: 395–401.

Jean G. , Vanel T. , Chazot C. , Charra B. , Terrat J.C. , Hurot J.M. Prevalence of stenosis and thrombosis of central veins in hemodialysis after a tunneled jugular catheter. Néphrologie 2001; 22: 501–4.

Thomas G.I. A large vessel applique arteriovenous shunt for hemodialysis. Trans ASAIO 1969; 15: 288–92.

Charra B. , Chazot C. The neglect of sodium restriction in dialysis patients: A short review. Hemodial Int 2003; 7: 342–7.

Charra B. , Chazot C. , Laurent G. , Calemard E. , Terrat J.C. , Vanel T. Clinical assessment of dry weight. Nephrol Dial Transplant 1996; 11(suppl 2): S16–9.

Charra B. , Jean G. , Hurot J.M. , Terrat J.C. , Vanel T. , Vo Van C. Clinical determination of dry body weight. Hemodial Int 2001; 5: 41–9.

Charra B. , Bergström J. , Scribner B.H. Blood Pressure control in dialysis patients. The importance of the lag phenomenon. Am J Kidney Dis 1998; 32: 720–4.

Daugirdas J.T. Bedside formulas for KT/V: A kinder, gentler approach to urea kinetic modeling. Trans ASAIO 1989; 35: 336–8.

Kaplan E.L. , Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.

Cox D.R. Regression models and life tables (with discussion). J Royal Stat Soc 1972; 34: 187–220.

Wolfe R.A. , Gaylin D.S. , Port F.K. , Held P.J. , Wood C.L. Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int 1992; 42: 991–6.

Coleman T.G. , Guyton A.C. Hypertension caused by salt loading in the dogs: III. Onset transient of cardiac output and other circulatory variables. Circ Res 1969; (suppl 5): S1–19.

Comty C. , Rottka H. , Shaldon S. Blood pressure control in patients with end-stage renal failure treated by intermittent dialysis. Proc EDTA 1964; 1: 209–14.

Vertes V. , Cangiano J.L. , Berman L.B. , Gould A. Hypertension in end-stage renal disease. N Engl J Med 1969; 280: 978–81.

Chobanian A.V. , Bakris G.L. , Black H.R. , Cushman W.C. , Green L.A. , Izzo J.L. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289: 2560–72.

Chazot C. , Charra B. , Laurent G. , Didier C. , Vo Van C. , Terrat J.C. Interdialysis blood pressure control by long hemodialysis sessions. Nephrol Dial Transplant 1995; 10: 831–7.

Berland Y. , Brunet P. Morbidity and mortality in hemodialysis: the role of schedules. Artif Organs 1995; 19: 827–31.

Schreiber M.J.J. Clinical case-based approach to understanding intradialytic hypotension. Am J Kidney Dis 2001; 38(suppl 4): S37–47.

Mailloux L.U. , Bellucci A.G. , Mossey R.T. Predictors of survival in patients undergoing dialysis. Am J Med 1988; 84: 855–62.

Collins A.J. , Hanson G. , Umen A. , Kjellstrand C. , Keshaviah P. Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis 1990; 15: 422–32.

Charra B. , Calemard E. , Cuche M. , Laurent G. Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 1983; 33: 96–9.

Charra B. Control of blood pressure in long slow hemodialysis. Blood Purif 1994; 12: 252–8.

Eliahou H.E. , Iaina A. , Reisen E. , Shapira J. Probability of survival in hypertensive and nonhypertensive patients on maintenance hemodialysis. Israel Journal of Medical Science 1977; 13: 33.

Degoulet P. , Reach I. , Rozenbaum W. , Aime F. , Devries C. , Berger C. Programme Dialyse-Informatique VI. Survie et Facteurs de Risque. Journal d'Urologie et de Nephrologie 1979; 85: 948–62.

Rostand S.G. , Brunzell J.D. , Cannon R.O. , Victor R.G. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991; 2: 1053–62.

Fernandez J.M. , Carbonell M.E. , Mazzuchi N. , Petrucelli D. Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients. Kidney Int 1992; 41: 1029–34.

Parfrey P.S. , Griffiths S.M. , Harnett J.D. , Barre P.E. Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Am J Nephrol 1990; 10: 213–21.

Zager P. , Campbell M. , Skipper B. , Brown R. , Hunt C. , Peterson D. Effect of blood pressure on mortality in hemodialysis patients (Abstract). J Am Soc Nephrol 1994; 5: 534.

Haginoshita S. , Sakurabayashi T. , Miyazaki S. , Takeda T. , Takaesu Y. , Aoike I. “J” curve relationship between blood pressure and cardiovascular prognosis in long-term hemodialysis patients (Abstract). J Am Soc Nephrol 1997; 8: 237A.

Block G.A. , Hulbert-Shearon T.E. , Levin N.W. , Port F.K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607–17.

Bouvier-Colle M.H. , Vallin J. , Hatton F. , eds. Mortalité et causes de décès en France. Editions INSERM ed. Paris: Doin Editeurs; 1994.

United States Renal Data System. Cardiovascular special studies. In: Bethesda M.D. , ed. Department of health and human services national institutes of health. National Institute of Diabetes, Digestive and Kidney Diseases. Annual Data Report, 2001; pp. 147–59.

Degoulet P. , Legrain M. , Reach I. , Aimé F. , Devriès C. , Rojas P. Mortality risk factors in patients treated by chronic hemodialysis. Nephron 1982; 31: 103–10.

United States Renal Data System. U.S.R.D.S. 1993 Annual data report: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1993.

Charra B. , Calemard E. , Chazot C. , Terrat J.C. , Vanel T. , Ruffet M. Dose of dialysis: What index? Blood Purif 1992; 10: 13–21.

Charra B. , Chazot C. , Jean G. , Hurot J.M. , Vanel T. , Terrat J.C. Long 3×8 hr dialysis: A three-decade summary. J Nephrol 2003; 16(suppl 7): S64–9.

Mujais S.K. , Ivanovitch P. , Bereza A. , Vidovich M. Biocompatibility and the clinical choice of dialysis membranes. In: Bonomini V. , Berland Y. , eds. Dialysis membranes: Structure and predictions. Basel: Karger, 1995; pp. 101–9.

Shaldon S. , Koch K.M. Biocompatibility in hemodialysis. Artif Organs 1995; 19: 395–7.

Charra B. , Calemard E. , Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35–44.

Ackrill P. , Goldsmith D.J.A. , Covic A.A. , Venning M.C. , Ralston A.J. Outcome of long hours self-care haemodialysis in a single unit from 1969 through 1994. Nephrology 1997; 3(suppl 1): S536.

Buttimore A.L. , Lynn K.L. , Bailey R.R. , Robson R.A. , Little P. 25 years of universal home dialysis at Christchuch hospital. Nephrology 1997; 3(suppl 1): S559.

Covic A.A. , Goldsmith D.J.A. , Venning M.C. , Ackrill P. Long-hours home hemodialysis – The best renal replacement therapy method? Q J Med 1999; 92: 251–60.

Alloatti S. , Molino A. , Manes M. , Bonfant G. , Pellu V. Long nocturnal dialysis. Blood Purif 2002; 21: 131–6.

Friedman E.A. International comparisons of survival on dialysis: Are they reliable? Hemodial Int 2003; 7: 59–66.

Lowrie E.G. , Lew N.L. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458–82.

Kjellstrand C.M. , Hylander B. , Collins A.C. Mortality on dialysis-on the influence of early start, patient characteristics, and transplantation and acceptance rates. Am J Kidney Dis 1990; 15: 483–90.

Raine A.E.G. , Margreiter R. , Brunner F.P. , Ehrich J.H.H. , Geerlings W. , Landais P. Report on management of renal failure in Europe XXII. Nephrol Dial Transplant 1992; (suppl 2): S7–35.

Foley R.N. , Parfrey P.S. , Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 4): S16–24.

Flanigan M. Excess mortality in small dialysis centers, the result of dialyzing high risk patients. ASAIO J 1995; 41: 177–81.

Khan I.H. , Campbell M.K. , Cantarovitch D. , Catto D. , Delcroix C. , Edward N. Survival on renal replacement therapy in Europe: Is there a “centre” effect? Nephrol Dial Transplant 1996; 11: 300–7.

Rocco M.V. , Burkart J.M. Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol 1993; 4: 1993–2183.

Dorhout Mees E.J. Volaemia and blood pressure in renal failure: Have old truths been forgotten? Nephrol Dial Transplant 1995; 10: 1297–8.

Held P.J. , Blagg C.R. , Liska D.W. , Port F.K. , Hakim R. , Levin N. The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int 1992; 42(suppl 38): S16–21.

Teraoka S. , Toma H. , Nihei H. , Ota K. , Babazono T. , Ishikawa I. Current status of renal replacement therapy in Japan. Am J Kidney Dis 1995; 25: 151–64.

Collins A.J. , Ma J. , Umen A. , Keshaviah P.R. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23: 272–82.

Mailloux L.U. , Bellucci A. , Napolitano B. , Mossey R.T. , Wilkes B.M. , Bluestone P.A. Survival estimates for 683 patients from 1970 through 1989: Identification of risk factors for survival. Clin Nephrol 1994; 42: 127–35.

Chertow G.M. , Owen W.F.J. , Lazarus J.M. , Lew N.L. , Lowrie E.G. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 1999; 56: 1872–8.

Port F.K. , Ashby V.B. , Dhingra R.K. , Roys E.C. , Wolfe R.A. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061–6.

Kramer P. , Broyer M. , Brunner F.P. , Brynger H. Combined report on regular dialysis and transplantation in Europe. Proc EDTA 1982; 19: 4–59.

Wizemann V. , Kramer W. Short-term dialysis, long-term complications. Blood Purif 1987; 5: 193–201.

Hakim R.M. , Breyer J. , Ismail N. , Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661–9.

Parker T.F. , Husni L. , Huang W. , Lew M. , Lowrie E.G. , and the Dallas Nephrology Associates. Survival of hemodialysis patients in United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670–80.

Eknoyan G. , Beck G.J. , Cheung A.K. , Daugirdas J.T. , Greene T. , Kusek J.W. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010–9.

Hakim R.A. Assessing the adequacy of dialysis. Kidney Int 1990; 37: 822–32.

Vanholder R. , de Smet R. , Vogeleere P. , Ringoir S. Middle molecules: Toxicity and removal by hemodialysis and related strategies. Artif Organs 1995; 19: 1120–5.

Ahmad S. , Blagg C.R. , Scribner B.H. Center and home chronic hemodialysis. In: Schrier R.W. , Gottshalk C.W. , eds. Diseases of the kidney, IVth Edition. Boston, Toronto: Lippincot, Williams and Williams 1988; pp. 3281–322.

Charra B. , Scribner B.H. , Twardowski Z.J. , Bergström J. The middle molecule hypothesis revisited. Should short three times weekly hemodialysis be abandoned? Hemodial Int 2002; 6: 9–14.

Bergström J. , Mamoun H. , Anderstam B. Middle molecules isolated from uremic ultrafiltrate and normal urine induce dose-dependent inhibition of appetite in rat (Abstract). J Am Soc Nephrol 1994; 5: 488.

Severini G. , Diana L. , Giovanndrea R. , Sagliaschi G. Influence of uremic middle molecules on in vitro stimulated lymphocytes and Interleukin-2 production. ASAIO J 1996; 42: 64–7.

Cheung A.K. Quantitation of dialysis: the importance of membrane and middle molecules. Blood Purif 1994; 12: 42–53.

Mucsi I. , Hercz G. , Uldall R. , Ouwendyk M. , Francoeur R. , Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998; 53: 1399–404.

Kopple J.D. , Henry D.A. , Roberts C.E. , Goodman W.G. , Blumenkrantz M.J. Relationship between nutritional status of patients undergoing maintenance hemodialysis and duration of dialysis therapy. In: Giordano C. , Friedman E.A. , eds. Uremia. Pathobiology of patients treated for 10 years or more. Milano: Wichtig Editore, 1981: pp. 25–31.

Bergström J. Nutrition and adequacy of dialysis in hemodialysis patients. Kidney Int 1993; 43(suppl 41): S261–7.

Owen W.F.J. , Lew N.L. , Yan Lu S.M. , Lowrie E.G. , Lazarus J.M. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001–6.

Kopple J.D. , Shinaberger J. , Coburn J. , Sorensen M. Optimal dietary protein treatment during chronic hemodialysis. Trans ASAIO 1989; 15: 302–8.

Lindsay R.M. , Spanner E. A hypothesis: the protein rate is dependent upon the type and amount of treatment in dialysed uremic patients. Am J Kidney Dis 1989; 13: 382–9.

Bergström J. Why are dialysis patients malnourished? Am J Kidney Dis 1995; 26: 229–41.

Gutierrez A. , Alvestrand A. , Bergström J. , Beving H. , Lantz B. , Henderson L.W. Biocompatibility of hemodialysis membranes: a study in healthy subjects. Blood Purif 1994; 12: 95–105.

Slomovitz L.A. , Monteon F.J. , Grosvenor M. , Laidlaw S.A. , Kopple J.D. Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 1989; 35: 704–11.

Schulman G. , Hakim R.M. Improving outcomes in chronic hemodialysis patients: should dialysis be initiated earlier. Semin Dial 1996; 9: 225–8.

Kaysen G.A. Hypoalbuminemia in dialysis patients. Semin Dial 1996; 9: 249–56.

Bergström J. , Heimbürger O. , Lindholm B. , Qureshi A.R. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in HD patients (Abstract). J Am Soc Nephrol 1995; 6: 573.

Kannel W.B. Role of blood pressure in cardiovascular disease: the Framingham study. Angiology 1975; 26: 1–14.

Stamler J. , Stamler R. , Neaton J.D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598–615.

Vincenti F. , Amend W.J. , Abele J. , Feduska N.J. , Salvatierra O. The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 1980; 63: 363–9.

Neff M.S. , Eiser A.R. , Slifkin R.F. , Baum M. , Baez A. , Gupta S. Patients surviving 10 years of hemodialysis. Am J Med 1983; 74: 996–1004.

Lindner A. , Charra B. , Sherrard D. , Blagg C. , Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697–701.

Parfrey P.S. , Foley R.N. , Harnett J.D. , Kent G.M. , Murray D. , Barre P.E. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49: 1428–34.

Tomita J. , Kimura G. , Inoue T. , Takashi I. , Sanai T. , Nakamura S. Role of systolic blood pressure in determining prognosis of hemodialysis patients. Am J Kidney Dis 1995; 25: 405–12.

Heyka R.L. , Paganini E.P. Blood pressure control in chronic dialysis patients. In: Maher J.F. , ed. Replacement of renal function by dialysis, 3rd ed. Dordrecht, Boston, Lancaster: Kluwer Academic Publishers, 1989: pp. 772–87.

Covic A.A. , Goldsmith D.J.A. Ambulatory blood pressure monitoring in nephrology: Focus on BP variability. J Nephrol 1999; 12: 220–9.

Mac Gregor D.O. , Buttimore A.L. , Lynn K.L. , Nicholls G.M. , Jardine R.S. A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purif 2001; 19: 293–300.

Kjellstrand K.M. , Evans R.L. , Petersen R.J. , Shideman J.R. , von Hartitzsch B. , Buselmeier T.J. The “unphysiology” of dialysis: a major cause of dialysis side effects? Kidney Int 1975; 10(suppl 7): S30–4.

Buoncristiani U. , Fagugli R. , Pinciaroli M.R. , Kulurianu H. , Bova C. Optimal blood pressure control with daily hemodialysis (Abstract). Perit Dial Int 1996; 16: 99.

Pierratos A. Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 1999; 14: 2835–40.

Traeger J. , Galland R. , Arkouche W. , Delawari E. , Fouque D. Short daily hemodialysis: A four-year experience. Dial Transplant 2001; 30: 76–86.

Scribner B.H. A personalized history of chronic hemodialysis. Am J Kidney Dis 1990; 6: 511–9.

Katzarski K.S. , Charra B. , Luik A. , Nisell J. , Divinho Filho J.C. , Leypoldt J.K. Fluid state and blood pressure control in patients treated with long and short hemodialysis. Nephrol Dial Transplant 1999; 14: 369–75.

Charra B. How important is volume excess in the etiology of hypertension in dialysis patients? Semin Dial 1999; 12: 297–9.

Fagugli R.M. , Ciao G. , Cicconi B. , Pasticci F. , Pasini P. Extracellular water decrease obtained by standard (SHD) or daily hemodialysis (DHD) allows cardiac hypertrophy reduction in hypertensive hemodialysis patients (Abstract). Nephrol Dial Transplant 1999; 14: A183.

Traeger J. , Galland R. , Delawari E. , Arkouche W. Daily versus standard hemodialysis: One year experience. Artif Organs 1998; 22: 558–63.

Özkahya M. , Töz H. , Ünsal A. , Özerkan F. , Asci G. , Gürgün C. Treatment of hypertension in dialysis patients by ultrafiltration: Role of cardiac dilatation and time factor. Am J Kidney Dis 1999; 34: 218–21.

Günal A.I. , Duman S. , Ozkahya M. , Toz H. , Asci G. , Akçiçek F. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588–93.

Lameire N. , van Biesen W. Importance of blood pressure and volume control in peritoneal dialysis patients. Perit Dial Int 2001; 21: 206–11.

Luik A.J. , Charra B. , Katzarski K.S. , Habets J. , Cheriex E.C. , Menheere PPCA . Blood pressure control and hemodynamic changes in patients on long time dialysis treatment. Blood Purif 1998; 16: 197–209.

Salem M.M. Hypertension in the hemodialysis population: any relationship to 2-year survival? Nephrol Dial Transplant 1999; 14: 125–8.

Port S. , Demer L. , Jennrich R. , Walter D. , Garfinkel A. Systolic blood pressure and mortality. Lancet 2000; 355: 175–80.

Zager P.G. , Nikolic J. , Brown R.H. , Campbell M.A. , Hunt W.C. , Peterson D. “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998; 54: 561–9.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Murray D.C. , Barre P.E. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379–85.

Ritz E. , Wiecek A.M.R. Cardiovascular death in patients with end-stage renal failure; strategies for prevention. In: Andreucci V.E. , Fine L.G. , eds. Yearbook of Nephrology: Oxford University Press, 1994: pp. 120–8.

Cheigh J.S. , Milite C. , Sullivan J.F. , Rubin A.L. , Stenzel K.H. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992; 19: 453–9.

Rahman M. , Griffin V. , Kumar A. , Manzoor F. , Wright J.T.J. , Smith M.C. A comparison of standardized versus “usual” blood pressure measurements in hemodialysis patients. Am J Kidney Dis 2002; 39.

Sulkova S. , Valek A. Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment. Kidney Int 1988; 34(suppl 25): S198–200.

Mailloux L.U. , Herbert L. , Mossey R.T. Interdialytic hypertension. Semin Dial 1993; 6: 409–10.

Wizemann V. , Timio M. Dialysis schedule-related fluid state and cardiovascular effects. Nephrol Dial Transplant 1998; 13(suppl 6): S91–3.

Vallance P. , Leone A. , Calver A. , Collier J. , Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572–5.

Converse R.L. , Jacobsen T.N. , Toto R. , Jost C.M. , Cosentino F. , Fouad-Tarazi F. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1996; 327: 1912–8.

Blasi E.R. , Rocha R. , Rudolph A.E. , Blomme E.A. , Polly M.L. , McMahon E.G. Kidney Int 2003; 63: 1791–800.

Cambi V. , Nizzoli M. , Paganelli E. , David S. , Bono F. Danger of unnecessarily prolonged dialysis session: Carpal tunnel syndrome. Artif Organs 1986; 10: 178–81.

Chanard J. , Vincent C. , Caudwell V. , Lavaud S. , Toupance O. , Wong T. Beta-2-microglobulin metabolism in uremic patients who are undergoing dialysis. Kidney Int 1993; 41(suppl): S83–7.

van Ypersele de Strihou C. , Jadoul M. , Malghem J. , Maldague B. , Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis related amyloidosis. Kidney Int 1991; 39: 1012–9.

Brunner F.P. , Selwood N.H. Results of renal replacement therapy in Europe, 1980 to 1987. Am J Kidney Dis 1990; 15: 384–96.

Kessler M. , Hestin D. , Aymard B. , Mainard D. , Claudon M. , Netter P. Carpal tunnel syndrome with ß-2 amyloid deposits and erosive arthropathy of the wrist and spine in a uremic patient before chronic hemodialysis. Nephrol Dial Transplant 1995; 10: 29.

Locatelli F. , Mastrangelo F. , Redaelli B. , Ronco C. , Marcelli D. , Orlandini G. The effects of different membranes and dialysis technologies on the treatment tolerance and nutritional parameters of hemodialysis patients. Design of a prospective randomised multicentre trial. J Nephrol 1994; 7: 123–9.

Gagnon R.F. , Lough J.O. , Bourgouin P. Carpal tunnel syndrome with ß2-microglobulin containing amyloid during continuous ambulatory peritoneal dialysis. Can Med Assoc J 1988; 139: 753–5.

Zingraff J.J. , Noël L.H. , Bardin T. , Atienza C. , Zins B. , Drüecke T.B. ß2-Microglobulin amyloidosis in chronic renal failure. N Engl J Med 1990; 323: 1070–1.

Davison A.M. Amyloidosis in patients with end-stage renal failure: uremia associated or dialysis related? In: Bonomini V. , Berland Y. , eds. Dialysis membranes: Structure and predictions. Basel: Karger, 1995: pp. 93–100.

Silberberg J.S. , Barré P.E. , Pritchard S.S. , Sniderman A.D. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286–90.

Covic A.A. , Goldsmith D.J.A. , Georgescu G. , Venning M.C. , Ackrill P. Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 1996; 45: 104–10.

Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 1998; 13(suppl 6): S148–51.

Pierratos A. Daily hemodialysis: An update. Curr Opin Nephrol Hypertens 2002; 11: 165–71.

Lindsay R.M. , Heidenheim A.P. , Leitch R. , Ryan H. , Kroeker A. , Peters K. Short daily versus long nocturnal hemodialysis. ASAIO J 2001; 47: 449–55.